Literature DB >> 16223847

Intron 1 sequences are required for pancreatic expression of the human proglucagon gene.

Li Zhou1, Min Nian, Jun Gu, David M Irwin.   

Abstract

The mammalian proglucagon gene is expressed in pancreatic islet A-cells, intestinal L-cells, and select neurons of the brain, where posttranslational processing results in the liberation of a unique profile of peptides. Despite the importance of proglucagon-derived peptides in human biology, little is known about the regulation of the human gene, as the rat gene has been the preferred model for understanding the regulation of proglucagon gene expression. Previously, we have shown that although the immediate promoter region of the rat proglucagon gene is sufficient for expression in pancreatic islet cells, the homologous human proglucagon promoter sequences are not sufficient. We have now used a comparative genomic approach to identify noncoding sequences near the human proglucagon gene that are conserved among mammals, and thus potentially are regulatory sequences. Our alignments identified three evolutionarily conserved noncoding regions (ECR), one is the immediate promoter region (ECR1), the second is about 5 kb 5' to the mRNA start site (ECR2), and the third is near the 3' end of the first intron (ECR3). Our in vitro transient transfection assays with reporter gene constructs that include the human ECR3 support expression in rodent islet cell lines. Complementary studies with transgenic mice possessing a reporter gene regulated by a human proglucagon gene promoter-intron 1 (including ECR3) sequences express the reporter gene in the pancreas, as well as the intestine and selected neurons. These studies suggest that conserved sequences within intron 1 of the human proglucagon gene are important for expression in the pancreas.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16223847     DOI: 10.1152/ajpregu.00596.2005

Source DB:  PubMed          Journal:  Am J Physiol Regul Integr Comp Physiol        ISSN: 0363-6119            Impact factor:   3.619


  7 in total

1.  Direct regulation of the proglucagon gene by insulin, leptin, and cAMP in embryonic versus adult hypothalamic neurons.

Authors:  Prasad S Dalvi; Frederick D Erbiceanu; David M Irwin; Denise D Belsham
Journal:  Mol Endocrinol       Date:  2012-06-05

Review 2.  Glucagon-like peptide 1 (GLP-1).

Authors:  T D Müller; B Finan; S R Bloom; D D'Alessio; D J Drucker; P R Flatt; A Fritsche; F Gribble; H J Grill; J F Habener; J J Holst; W Langhans; J J Meier; M A Nauck; D Perez-Tilve; A Pocai; F Reimann; D A Sandoval; T W Schwartz; R J Seeley; K Stemmer; M Tang-Christensen; S C Woods; R D DiMarchi; M H Tschöp
Journal:  Mol Metab       Date:  2019-09-30       Impact factor: 7.422

3.  The pancreatic islet β-cell-enriched transcription factor Pdx-1 regulates Slc30a8 gene transcription through an intronic enhancer.

Authors:  Lynley D Pound; Yan Hang; Suparna A Sarkar; Yingda Wang; Laurel A Milam; James K Oeser; Richard L Printz; Catherine E Lee; Roland Stein; John C Hutton; Richard M O'Brien
Journal:  Biochem J       Date:  2011-01-01       Impact factor: 3.857

4.  Research Resource: Genetic Labeling of Human Islet Alpha Cells.

Authors:  Philip T Pauerstein; Keon Min Park; Heshan S Peiris; Jing Wang; Seung K Kim
Journal:  Mol Endocrinol       Date:  2016-01-08

5.  Targeted ablation of glucose-dependent insulinotropic polypeptide-producing cells in transgenic mice reduces obesity and insulin resistance induced by a high fat diet.

Authors:  Matthew C Althage; Eric L Ford; Songyan Wang; Patrick Tso; Kenneth S Polonsky; Burton M Wice
Journal:  J Biol Chem       Date:  2008-04-17       Impact factor: 5.157

6.  Clinical relevance of peroxisome proliferator-activated receptor-γ gene polymorphisms with sepsis.

Authors:  Yu Liu; Wenhui Wan; Fang Fang; Lei Guo; Yusheng Zhao; Xinghu Zhang; Fang Huang
Journal:  J Clin Lab Anal       Date:  2017-10-21       Impact factor: 2.352

7.  Characterization of the human SLC30A8 promoter and intronic enhancer.

Authors:  Lynley D Pound; Suparna A Sarkar; Stéphane Cauchi; Yingda Wang; James K Oeser; Catherine E Lee; Philippe Froguel; John C Hutton; Richard M O'Brien
Journal:  J Mol Endocrinol       Date:  2011-09-30       Impact factor: 5.098

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.